Tel: +86-917-8888998
Home > News > Content
Categories

Baoji Herbest Bio-Tech Co.,Ltd


tel: +86-917-8888998


fax:+86-917-3139802


phone:+8615319196488


email: root@herbest


Production Of Ginsenoside F1 Using Commercial Enzyme Cellulase KN.

Baoji Herbest Bio-Tech Co.,Ltd | Updated: Apr 27, 2017

Production of ginsenoside F1 using commercial enzyme Cellulase KN.

Wang Y, Choi KD, Yu H, Jin F, Im WT.

Abstract

BACKGROUND:

Ginsenoside F1, a pharmaceutical component of ginseng, is known to have antiaging, antioxidant, anticancer, and keratinocyte protective effects. However, the usage of ginsenoside F1 is restricted owing to the small amount found in Korean ginseng.

METHODS:

To enhance the production of ginsenoside F1 as a 10 g unit with high specificity, yield, and purity, an enzymatic bioconversion method was developed to adopt the commercial enzyme Cellulase KN from Aspergillus niger with food grade, which has ginsenoside-transforming ability. The proposed optimum reaction conditions of Cellulase KN were pH 5.0 and 50°C.

RESULTS:

Cellulase KN could effectively transform the ginsenosides Re and Rg1 into F1. A scaled-up biotransformation reaction was performed in a 10 L jar fermenter at pH 5.0 and 50°C for 48 h with protopanaxatriol-type ginsenoside mixture (at a concentration of 10 mg/mL) from ginseng roots. Finally, 13.0 g of F1 was produced from 50 g of protopanaxatriol-type ginsenoside mixture with 91.5 ± 1.1% chromatographic purity.

CONCLUSION:

The results suggest that this enzymatic method could be exploited usefully for the preparation of ginsenoside F1 to be used in cosmetic, functional food, and pharmaceutical industries.